Medipal Holdings Corp
TSE:7459
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
|
Medipal Holdings Corp
TSE:7459
|
591.5B JPY |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
120.3B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
68.5B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.6B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36.1B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.2B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.8B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.2B USD |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.3B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -122 700% |
| 30th Percentile | 2.9% |
| Median | 5.4% |
| 70th Percentile | 8.5% |
| Max | 63 031.4% |
Other Profitability Ratios
Medipal Holdings Corp
Glance View
Medipal Holdings Corp., a longstanding pillar in Japan’s healthcare and pharmaceutical distribution network, tells a story of efficiency and dedication to health. Born from a strategic merger in the late 20th century, Medipal has established itself as a key player in the intricate world of pharmaceutical and medical supply logistics. The company's operations are woven into the fabric of Japan’s healthcare infrastructure, where precision and reliability form the foundation of its success. By orchestrating the smooth flow of pharmaceuticals, medical devices, and health-related products from manufacturers to a myriad of healthcare facilities and retail outlets, Medipal plays a vital role in ensuring that medical professionals and patients alike have timely access to necessary products. At the heart of Medipal's business model is a comprehensive supply chain that seamlessly connects an extensive network of partners. With sophisticated distribution centers operating as logistical powerhouses, Medipal leverages cutting-edge technology to optimize inventory management and delivery systems. This enables the company not only to drive efficiencies but also to create value by reducing costs and enhancing the speed and reliability of distributions. Revenue streams are generated primarily through distribution fees and the strategic management of logistics services. As Medipal continues to expand its reach and refine its operations, it remains steadfast in its commitment to being an indispensable ally in Japan's healthcare landscape, where reliability and trust are of paramount importance.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Medipal Holdings Corp is 1.1%, which is below its 3-year median of 1.2%.
Over the last 3 years, Medipal Holdings Corp’s Net Margin has increased from 0.8% to 1.1%. During this period, it reached a low of 0.8% on Sep 30, 2022 and a high of 1.4% on Dec 31, 2024.